IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Early Morning Neuroparalytic Syndrome

Case Report, Volume 03 Issue 2 – April to June 2010

Authors

Dr. Mohd Haneef, MD, PGDHS, Consultant Physician / Diabetologist, Koyili Hospital, Kannur, Kerala.


Abstract

Snake bite is a common problem seen in the rural parts of India and is associated with a high rate of mortality due to their re-lated toxicity. Neurotoxicity from the elapid bite may manifest as the early morning neuroparalytic syndrome (EMNS) or even as Locked in syndrome. Determining the types of toxicity in the patient is based on cl inical signs and laboratory findings or by direct examination of the snake. Patients presenting as EMNS do not have bite marks on their body and hence the diagnosis may be complicated. A 14 year old girl presented with a tingling sensation over her body who later developed respiratory failure is reported here. She was treated with a standard regimen of anti-snake venom (ASV) and atropine – neostigmine along with other supportive measures. She made a remarkable recovery with the above treatment and hence it is essential to consider a possibility of elapid envonomation in these patients presenting with acute neuroparalysis in snake bite endemic areas.


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician